Ophthalmic vein thrombosis and G1691A mutation of factor V gene
Desplat-Jego, S.; Coupier, L.; Aillaud, M.F.; Alessi, M.C.; Billerey, M.; Juhan-Vague, I.
Presse Medicale 28(11): 583
1999
ISSN/ISBN: 0755-4982 PMID: 10214381 Document Number: 502396
Document emailed within 1 workday
Related Documents
Levoir, D.; Aubertin, J.M.; Alhenc-Gelas, M.; Bloch, F.; Becheur, H.; Petite, J.P. 1995: A new hereditary cause of portal vein thrombosis: the abnormal resistance to activated protein C by the Arg 506-->Gln mutation of the gene of factor V Gastroenterologie Clinique et Biologique 19(8-9): 729-731Martinelli, I.; Landi, G.; Merati, G.; Cella, R.; Tosetto, A.; Mannucci, P.M. 1996: Factor V gene mutation is a risk factor for cerebral venous thrombosis Thrombosis and Haemostasis 75(3): 393-394
Samuelsson, E.; Hultdin, J.; Groth, K.; Hedenmalm, K. 2007: Axillary vein thrombosis in a young woman with a contraceptive ring. Prothrombin gene mutation a possible connection Lakartidningen 104(1-2): 32-34
Leroy-Matheron, C.; Levent, M.; Pignon, J.M.; Mendonça, C.; Gouault-Heilmann, M. 1996: The 1691 G-->A mutation in the factor V gene: relationship to activated protein C (APC) resistance and thrombosis in 65 patients Thrombosis and Haemostasis 75(1): 4-10
Nazli, Y.; Colak, N.; Aksoy, O.N.; Cakir, O. 2011: Thyroid vein thrombosis in a young woman with methylenetetrahydrofolate reductase gene mutation receiving cyproterone acetate/ethinylestradiol treatment for polycystic ovary syndrome: a case report Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 22(4): 331-333
Narawane, N.M.; Phadke, A.Y.; Shah, S.K.; Bhandarkar, P.V.; Abraham, P. 2000: Jejunal stricture complicating acute mesenteric venous thrombosis secondary to protein C deficiency and factor V Leiden gene mutation Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 19(2): 79-80
Boniuk, M. 1972: The ocular manifestations of ophthalmic vein and aseptic cavernous sinus thrombosis Transactions - American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology 76(6): 1519-1534
Jaais, F.; Habib, Z.A. 1994: Unilateral superior ophthalmic vein thrombosis in a user of oral contraceptives Medical Journal of Malaysia 49(4): 416-418
Takahashi, Y.; Ishikawa, Y.; Odashima, S.; Chikuda, M.; Tazawa, Y. 1984: A clinical picture of the superior ophthalmic vein thrombosis--based upon our 4 cases and review of the literature Nippon Ganka Gakkai Zasshi 88(7): 1075-1083
Dahlbäck, B. 1997: Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis Thrombosis and Haemostasis 78(1): 483-488
Abad, C.; Justo-García, I.; Fuertes del Teso, D.; Muzas, A. 2006: Portal and mesenteric vein thrombosis in a patient with a mutation of the 20210 gen of the prothrombin Anales de Medicina Interna 23(11): 555-556
Tondeur, S.; Boutruche, S.; Biron-Andréani, C.; Schved, J-François. 2009: Prevalence of the JAK2 V617F mutation associated with splanchnic vein thrombosis. A 10-year retrospective study Thrombosis and Haemostasis 101(4): 787-789
Al-Hilali, A.; Wulff, K.; Abdel-Razeq, H.; Saud, K.Abu.; Al-Gaili, F.; Herrmann, F.H. 2007: Analysis of the novel factor X gene mutation Glu51Lys in two families with factor X-Riyadh anomaly Thrombosis and Haemostasis 97(4): 542-545
de Suray, N.; Pranger, D.; Brenard, R. 2008: Portal vein thrombosis as the first sign of a primary myeloproliferative disorder: diagnostic interest of the V617F JAK-2 mutation. A report of 2 cases Acta Gastro-Enterologica Belgica 71(1): 39-41
Howard, T.E.; Marusa, M.; Channell, C.; Duncan, A. 1997: A patient homozygous for a mutation in the prothrombin gene 3'-untranslated region associated with massive thrombosis Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 8(5): 316-319
Hirmerova, J.; Seidlerova, J.; Subrt, I. 2013: Deep vein thrombosis and/or pulmonary embolism concurrent with superficial vein thrombosis of the legs: cross-sectional single center study of prevalence and risk factors International Angiology: a Journal of the International Union of Angiology 32(4): 410-416
Keller, D.I.; Barrane, F-Zahara.; Gouas, L.; Martin, J.; Pilote, S.; Suarez, V.; Osswald, S.; Brink, M.; Guicheney, P.; Schwick, N.; Chahine, M. 2005: A novel nonsense mutation in the SCN5A gene leads to Brugada syndrome and a silent gene mutation carrier state Canadian Journal of Cardiology 21(11): 925-931
González Ordóñez, A.J.; Medina Rodriguez, J.M.; Fernández Alvarez, C.R.; Macias Robles, M.D.; Coto García, E. 1998: A patient homozygous for mutation 20210A in the prothrombin gene with venous thrombosis and transient ischemic attacks of thrombotic origin Haematologica 83(11): 1050-1051
Moor, E.; Silveira, A.; van't Hooft, F.; Tornvall, P.; Blombäck, M.; Wiman, B.; Rydén, L.; Hamsten, A. 1998: Coagulation factor V (Arg506-->Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass grafting Thrombosis and Haemostasis 80(2): 220-224
Soubrier, F.; Fery, I.; Verdy, E.; René, M.N.; Varsat, B.; Visvikis, S.; Siest, G. 1995: The frequency of the factor V gene R506Q mutation varies between regions of France Nouvelle Revue Francaise d'Hematologie 37(2): 175